Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Liabilities and Shareholders Equity (2016 - 2025)

INVO Fertility (IVF) has disclosed Liabilities and Shareholders Equity for 15 consecutive years, with $18.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 42318.68% to $18.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $116.3 million, a 288.75% increase, with the full-year FY2024 number at $46.4 million, up 151.0% from a year prior.
  • Liabilities and Shareholders Equity was $18.8 million for Q3 2025 at INVO Fertility, down from $19.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $46.4 million in Q4 2024 to a low of -$375355.0 in Q1 2023.
  • A 5-year average of $12.0 million and a median of $9.5 million in 2021 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: crashed 104.65% in 2023, then soared 64343.27% in 2025.
  • INVO Fertility's Liabilities and Shareholders Equity stood at $10.0 million in 2021, then crashed by 62.88% to $3.7 million in 2022, then skyrocketed by 398.84% to $18.5 million in 2023, then soared by 151.0% to $46.4 million in 2024, then plummeted by 59.46% to $18.8 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Liabilities and Shareholders Equity are $18.8 million (Q3 2025), $19.3 million (Q2 2025), and $31.7 million (Q1 2025).